179 related articles for article (PubMed ID: 11012986)
1. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.
Zhu X; Kanai Y; Saito A; Kondo Y; Hirohashi S
Pathol Int; 2000 Dec; 50(12):945-52. PubMed ID: 11123760
[TBL] [Abstract][Full Text] [Related]
3. Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas.
Miyake N; Maeta H; Horie S; Kitamura Y; Nanba E; Kobayashi K; Terada T
Pathol Int; 2001 Sep; 51(9):680-5. PubMed ID: 11696170
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract][Full Text] [Related]
5. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
6. Analysis of beta-catenin gene mutations in pancreatic tumors.
Gerdes B; Ramaswamy A; Simon B; Pietsch T; Bastian D; Kersting M; Moll R; Bartsch D
Digestion; 1999; 60(6):544-8. PubMed ID: 10545724
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
11. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling pathway analysis in renal cell carcinoma in young patients.
Bruder E; Moch H; Ehrlich D; Leuschner I; Harms D; Argani P; Briner J; Graf N; Selle B; Rufle A; Paulussen M; Koesters R
Mod Pathol; 2007 Dec; 20(12):1217-29. PubMed ID: 17873895
[TBL] [Abstract][Full Text] [Related]
13. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
14. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion.
Miyazawa K; Iwaya K; Kuroda M; Harada M; Serizawa H; Koyanagi Y; Sato Y; Mizokami Y; Matsuoka T; Mukai K
Virchows Arch; 2000 Nov; 437(5):508-13. PubMed ID: 11147171
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin alteration in cancer of the ampulla of Vater.
Kawakami M; Kimura Y; Furuhata T; Zenbutsu H; Yanai Y; Mukaiya M; Satoh Y; Murata S; Hirata K
J Exp Clin Cancer Res; 2002 Mar; 21(1):23-7. PubMed ID: 12071524
[TBL] [Abstract][Full Text] [Related]
16. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus.
Bian YS; Osterheld MC; Bosman FT; Fontolliet C; Benhattar J
Am J Clin Pathol; 2000 Oct; 114(4):583-90. PubMed ID: 11026105
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
18. Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.
Palacios J; Catasús L; Moreno-Bueno G; Matias-Guiu X; Prat J; Gamallo C
Virchows Arch; 2001 May; 438(5):464-9. PubMed ID: 11407474
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
20. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]